FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Watson Buchanan

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Géza P Bálint; W Watson Buchanan; András Adám; István Ratkó; László Poór; Péter V Bálint; Eva Somos; Ildikó Tefner; Tamás Bender
The effect of the thermal mineral water of Nagybaracska on patients with knee joint osteoarthritis--a double blind study.
Géza P Bálint; Walter F Kean; W Watson Buchanan
Sir William Osler (1849-1919): his opinion of modern therapeutics.
Geza P Balint; W Watson Buchanan; Jan Dequeker
A brief history of medical taxonomy and diagnosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Watson Buchanan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Géza P Bálint; W Watson Buchanan; András Adám; István Ratkó; László Poór; Péter V Bálint; Eva Somos; Ildikó Tefner; Tamás Bender
The effect of the thermal mineral water of Nagybaracska on patients with knee joint osteoarthritis--a double blind study.
Clinical rheumatology 2007;26(6):890-4.
2006: Géza P Bálint; Walter F Kean; W Watson Buchanan
Sir William Osler (1849-1919): his opinion of modern therapeutics.
Scottish medical journal 2006;51(1):51-3.
2006: Geza P Balint; W Watson Buchanan; Jan Dequeker
A brief history of medical taxonomy and diagnosis.
Clinical rheumatology 2006;25(2):132-5.
2005: W Watson Buchanan; Walter F Kean
An unusual crystal.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2005;173(8):850; author reply 850.
2005: Walter F Kean; W Watson Buchanan
The use of NSAIDs in rheumatic disorders 2005: a global perspective.
Inflammopharmacology 2005;13(4):343-70.
2004: W Watson Buchanan
Did the tenth-century viking Egil Skallagrimsson (c.AD 910-990) have Paget's disease?
The journal of the Royal College of Physicians of Edinburgh 2004;34(3):244-6.
2004: Walter F Kean; R Kean; W Watson Buchanan
Osteoarthritis: symptoms, signs and source of pain.
Inflammopharmacology 2004;12(1):3-31.
2003: W Watson Buchanan
Sir Benjamin Collins Brodie (1783-1862).
Rheumatology (Oxford, England) 2003;42(5):689-91.
2003: W Watson Buchanan; Walter F Kean; Robert Kean
History and current status of osteoarthritis in the population.
Inflammopharmacology 2003;11(4):301-16.
2003: W Watson Buchanan; Walter F Kean
Dr William Bruce (1835-1920), the scottish highland spa at strathpeffer; and a possible description of polymyalgia rheumatica.
The journal of the Royal College of Physicians of Edinburgh 2003;33(Suppl 12):29-35.
2002: W Watson Buchanan
Placebo tribulations.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002;167(5):456; author reply 456-7.
2002: W Watson Buchanan; Walter F Kean
The treatment of acute rheumatism by salicin, by T.J. Maclagan--The Lancet, 1876.
The Journal of rheumatology 2002;29(6):1321-3.
2001: Marek Smieja; D W MacPherson; Walter F Kean; Mary Lou Schmuck; Charles H Goldsmith; W Watson Buchanan; Lawrence E Hart; James B Mahony
Randomised, blinded, placebo controlled trial of doxycycline for chronic seronegative arthritis.
Annals of the rheumatic diseases 2001;60(12):1088-94.
2001: W Watson Buchanan; Walter F Kean
Evidence based medicine: the median is not the message.
The Journal of rheumatology 2001;28(11):2371-2.
2001: W Watson Buchanan; Walter F Kean
Clinical judgement and evidence-based medicine.
Joint, bone, spine : revue du rhumatisme 2001;68(5):370-2.
2001: W Watson Buchanan; Walter F Kean
Rheumatoid arthritis: beyond the lymphocyte.
The Journal of rheumatology 2001;28(4):691-3.
2000: W Watson Buchanan
Jamie the Saxt's A Counterblaste to tobacco.
Proceedings of the Royal College of Physicians of Edinburgh 2000;30(2):154-7.
1997: Walter F Kean; Lawrence Hart; W Watson Buchanan
Auranofin.
British journal of rheumatology 1997;36(5):560-72.
1997: DP Singal; M Ye; W Watson Buchanan; X Qiu
HLA-D region genes and susceptibility to rheumatoid arthritis.
Transplantation proceedings 1997;29(1-2):1126.
1996: DP Singal; M Ye; H Fleisig; W Watson Buchanan; X Qiu
Y box-binding trans-regulatory nuclear proteins and susceptibility to rheumatoid arthritis.
Clinical and experimental rheumatology 1996;14(6):669-72.
1994: S Barr; Nicholas Bellamy; W Watson Buchanan; Andrew Chalmers; P M Ford; W F Kean; G R Kraag; E Gerecz-Simon; J Campbell
A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index. Western Ontario and McMaster Universities Osteoarthritis Index.
The Journal of rheumatology 1994;21(11):2106-12.
1994: W Watson Buchanan
Rheumatoid arthritis: another New World disease?
Seminars in arthritis and rheumatism 1994;23(5):289-94.
1994: DP Singal; A Sastry; W Watson Buchanan
HLA-DPB1 alleles in patients with rheumatoid arthritis.
Clinical and experimental rheumatology 1994;12(2):183-6.
1994: K F al-Jarallah; W Watson Buchanan; A Sastry; DP Singal
Seronegative rheumatoid arthritis and HLA-DR4.
The Journal of rheumatology 1994;21(2):190-3.
1993: K F al-Jarallah; W Watson Buchanan; A Sastry; DP Singal
Immunogenetics of polymyalgia rheumatica.
Clinical and experimental rheumatology 1993;11(5):529-31.
1993: Nicholas Bellamy; W Watson Buchanan; Andrew Chalmers; P M Ford; W F Kean; G R Kraag; E Gerecz-Simon; J Campbell
A multicenter study of tenoxicam and diclofenac in patients with osteoarthritis of the knee.
The Journal of rheumatology 1993;20(6):999-1004.
1993: K F al-Jarallah; DP Singal; W Watson Buchanan
Immunogenetics of psoriatic arthritis.
Immunological investigations 1993;22(2):81-6.
1993: M Saghafi; M J Henderson; W Watson Buchanan
Sternocostoclavicular hyperostosis.
Seminars in arthritis and rheumatism 1993;22(4):215-23.
1992: K F al-Jarallah; D K Shehab; W Watson Buchanan
Rheumatic complications of alcohol abuse.
Seminars in arthritis and rheumatism 1992;22(3):162-71.
1992: W F Kean; E J Antal; E M Grace; H Cauvier; J Rischke; W Watson Buchanan
The pharmacokinetics of flurbiprofen in younger and elderly patients with rheumatoid arthritis.
Journal of clinical pharmacology 1992;32(1):41-8.
1992: Nicholas Bellamy; W F Kean; W Watson Buchanan; E Gerecz-Simon; J Campbell
Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis Index.
The Journal of rheumatology 1992;19(1):153-9.
1992: DP Singal; D Green; B Reid; D D Gladman; W Watson Buchanan
HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA.
Annals of the rheumatic diseases 1992;51(1):23-8.
1991: Nicholas Bellamy; T P Anastassiades; W Watson Buchanan; P Davis; P Lee; G A McCain; G A Wells; J Campbell
Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs.
The Journal of rheumatology 1991;18(12):1901-7.
1991: Nicholas Bellamy; T P Anastassiades; W Watson Buchanan; P Davis; P Lee; G A McCain; G A Wells; J Campbell
Rheumatoid arthritis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise.
The Journal of rheumatology 1991;18(12):1908-15.
1991: Nicholas Bellamy; T P Anastassiades; W Watson Buchanan; P Davis; P Lee; G A McCain; G A Wells; J Campbell
Rheumatoid arthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.
The Journal of rheumatology 1991;18(12):1893-900.
1991: Nicholas Bellamy; W Watson Buchanan; J M Esdaile; A G Fam; W F Kean; J M Thompson; G A Wells; J Campbell
Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise.
The Journal of rheumatology 1991;18(11):1716-22.
1991: Nicholas Bellamy; W Watson Buchanan; J M Esdaile; A G Fam; W F Kean; J M Thompson; G A Wells; J Campbell
Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials.
The Journal of rheumatology 1991;18(11):1709-15.
1991: Nicholas Bellamy; W Watson Buchanan; J M Esdaile; A G Fam; W F Kean; J M Thompson; G A Wells; J Campbell
Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.
The Journal of rheumatology 1991;18(11):1701-8.
1991: W Watson Buchanan; W F Kean; J St-Jean; E Gerecz-Simon; R Elie
Clinical evaluation of a sustained release compared to a standard formulation of tiaprofenic acid (Surgam) in rheumatoid arthritis: a Canadian multicenter study.
The Journal of rheumatology 1991;18(7):1046-54.
1991: W Watson Buchanan
Bernardino Ramazzini (1633-1714) physician of tradesmen, and possibly one of the "fathers" of sports medicine.
Clinical rheumatology 1991;10(2):136-7.
1991: Nicholas Bellamy; Robert Sothern; J Campbell; W Watson Buchanan
Circadian rhythm in pain, stiffness, and manual dexterity in rheumatoid arthritis: relation between discomfort and disability.
Annals of the rheumatic diseases 1991;50(4):243-8.
1991: N Bellamy; C H Goldsmith; W Watson Buchanan; J Campbell; Eric Duku
Prior score availability: observations using the WOMAC osteoarthritis index.
British journal of rheumatology 1991;30(2):150-1.
1991: C T McCusker; B Reid; D Green; D D Gladman; W Watson Buchanan; DP Singal
HLA-D region antigens in patients with rheumatoid arthritis.
Arthritis and rheumatism 1991;34(2):192-7.
1991: B Reid; D Green; W Watson Buchanan; DP Singal
HLA-D region and Hsp70 genes in rheumatoid arthritis.
Transplantation proceedings 1991;23(1 Pt 1):457-8.
1991: W F Kean; C J Lock; D Somers; J Rischke; L Nablo; Y B Kassam; M G Hogan; W Watson Buchanan; H E Howard-Lock
Action of gold sodium thiomalate on experimental thrombosis in vivo.
Journal of pharmaceutical sciences 1991;80(2):113-8.
1990: W Watson Buchanan; DP Singal
Is there a need to reclassify adult rheumatoid arthritis?
British journal of rheumatology 1990;29(5):377-81.
1990: DP Singal; B Reid; D Green; M D'Souza; WG Bensen; W Watson Buchanan
Polymorphism of major histocompatibility complex extended haplotypes bearing HLA-DR3 in patients with rheumatoid arthritis with gold induced thrombocytopenia or proteinuria.
Annals of the rheumatic diseases 1990;49(8):582-6.
1990: E Gerecz-Simon; W Y Soper; W F Kean; P J Rooney; Peter Tugwell; W Watson Buchanan
A controlled comparison of piroxicam and diclofenac in patients with osteoarthritis.
Clinical rheumatology 1990;9(2):229-34.
1990: Nicholas Bellamy; W Watson Buchanan; Charles H Goldsmith; J Campbell; Eric Duku
Signal measurement strategies: are they feasible and do they offer any advantage in outcome measurement in osteoarthritis?
Arthritis and rheumatism 1990;33(5):739-45.
1990: Peter Tugwell; C Bombardier; W Watson Buchanan; C Goldsmith; E Grace; Kathryn J Bennett; H J Williams; M Egger; G S Alarcon; M Guttadauria
Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires.
Archives of internal medicine 1990;150(1):59-62.
1990: P J Rooney; R T Jenkins; W Watson Buchanan
A short review of the relationship between intestinal permeability and inflammatory joint disease.
Clinical and experimental rheumatology 1990;8(1):75-83.
1989: E M Gerecz-Simon; E R Tunks; J A Heale; W F Kean; W Watson Buchanan
Measurement of pain threshold in patients with rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and healthy controls.
Clinical rheumatology 1989;8(4):467-74.
1989: W F Kean; C J Lock; J Rischke; R Butt; W Watson Buchanan; H Howard-Lock
Effect of R and S enantiomers of naproxen on aggregation and thromboxane production in human platelets.
Journal of pharmaceutical sciences 1989;78(4):324-7.
1989: DP Singal; M D'Souza; B Reid; Y Kassam; W Watson Buchanan; Morris A Blajchman
Molecular analysis of the HLA-D region and the T-cell antigen receptor beta-chain genes in monozygotic twins discordant for rheumatoid arthritis.
Transplantation proceedings 1989;21(1 Pt 1):632-4.
1988: H M Buchanan; W Watson Buchanan; W P Cockshott; Markad V Kamath; D N Ghista
Radiological changes in rheumatoid arthritis: measurement of area of juxta-articular bone as outcome event in clinical therapeutic trials of antirheumatic drugs.
Clinical rheumatology 1988;7(4):481-5.
1988: Nicholas Bellamy; W Watson Buchanan; Charles H Goldsmith; J Campbell; Larry Stitt
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.
The Journal of rheumatology 1988;15(12):1833-40.
1988: E M Grace; E M Gerecz; Y B Kassam; H M Buchanan; W Watson Buchanan; P S Tugwell
50-foot walking time: a critical assessment of an outcome measure in clinical therapeutic trials of antirheumatic drugs.
British journal of rheumatology 1988;27(5):372-4.
1988: W Watson Buchanan; L J Stephen; H M Buchanan
Are 'homeopathic' doses of oral corticosteroids effective in rheumatoid arthritis?
Clinical and experimental rheumatology 1988;6(3):281-4.
1988: D Ludwin; Kathryn J Bennett; E M Grace; W Watson Buchanan; WG Bensen; C Bombardier; Peter Tugwell
Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine.
Transplantation proceedings 1988;20(3 Suppl 4):367-70.
1988: Alice Klinkhoff; Nicholas Bellamy; C Bombardier; S Carette; Andrew Chalmers; J M Esdaile; C Goldsmith; Peter Tugwell; H A Smythe; W Watson Buchanan
An experiment in reducing interobserver variability of the examination for joint tenderness.
The Journal of rheumatology 1988;15(3):492-4.
1987: Peter Tugwell; C Bombardier; M Gent; K Bennett; D Ludwin; E Grace; W Watson Buchanan; WG Bensen; N Bellamy; G F Murphy
Low dose cyclosporine in rheumatoid arthritis: a pilot study.
The Journal of rheumatology 1987;14(6):1108-14.
1987: W Watson Buchanan; W F Kean; D G Palmer
The contribution of William Hunter (1718-1783) to the study of bone and joint disease.
Clinical rheumatology 1987;6(4):489-503.
1987: A A Mewa; D Rosenbloom; E M Grace; P Brooks; N Bellamy; C Denko; G Norman; W Watson Buchanan
Effects of aspirin, naloxone and placebo.
Clinical rheumatology 1987;6(4):526-31.
1987: Jonathan D Adachi; WG Bensen; Y Kassam; P J Powers; F A Bianchi; AA Cividino; W F Kean; P J Rooney; G L Craig; W Watson Buchanan
Gold induced thrombocytopenia: 12 cases and a review of the literature.
Seminars in arthritis and rheumatism 1987;16(4):287-93.
1987: Y B Kassam; W F Kean; C J Lock; W Watson Buchanan; G T Simon; D A Harvey
Variation in physical and biological properties of solid gold sodium thiomalate on dissolution: an electron microscopic and energy dispersive spectroscopic study.
The Journal of rheumatology 1987;14(2):209-15.
1987: E M Grace; JM Rosenfeld; G D Sweeney; W Watson Buchanan
The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritis.
Current medical research and opinion 1987;10(9):580-91.
1986: E M Grace; A A Mewa; G D Sweeney; JM Rosenfeld; A C Darke; W Watson Buchanan
Lowering of plasma isoxicam concentrations with acetylsalicylic acid.
The Journal of rheumatology 1986;13(6):1119-21.
1985: W F Kean; F Forestier; Y Kassam; W Watson Buchanan; P J Rooney
The history of gold therapy in rheumatoid disease.
Seminars in arthritis and rheumatism 1985;14(3):180-6.
1985: E M Grace; N Bellamy; Y Kassam; W Watson Buchanan
Controlled, double-blind, randomized trial of amitriptyline in relieving articular pain and tenderness in patients with rheumatoid arthritis.
Current medical research and opinion 1985;9(6):426-9.
1984: W F Kean; C J Lock; Y B Kassam; P J Rooney; J Rischke; L Nablo; W Watson Buchanan
A biological effect on platelets by the minor component of gold sodium thiomalate--a by-product of heat sterilization and exposure to light.
Clinical and experimental rheumatology 1984;2(4):321-8.
1984: Peter Tugwell; L Hart; G Kraag; A Park; C Dok; F Bianchi; C Goldsmith; W Watson Buchanan
Controlled trial of clinical utility of serum salicylate monitoring in rheumatoid arthritis.
The Journal of rheumatology 1984;11(4):457-61.
1984: W F Kean; Y B Kassam; C J Lock; W Watson Buchanan; J Rischke; L Nablo
Antithrombin activity of gold sodium thiomalate.
Clinical pharmacology and therapeutics 1984;35(5):627-32.
1984: P M Brooks; W F Kean; Y Kassam; W Watson Buchanan
Problems of antiarthritic therapy in the elderly.
Journal of the American Geriatrics Society 1984;32(3):229-34.
1983: E M Grace; A Mewa; P J Rooney; W Watson Buchanan
Clinical therapeutic trial of sodium meclofenamate and naproxen in rheumatoid arthritis, with comments on the use of placebos in clinical trials.
Current medical research and opinion 1983;8(6):417-24.
1982: W F Kean; C J Lock; H E Howard-Lock; W Watson Buchanan
Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
Arthritis and rheumatism 1982;25(8):917-22.